Literature DB >> 27859648

Limitations of serum ferritin to predict liver iron concentration responses to deferasirox therapy in patients with transfusion-dependent thalassaemia.

John B Porter1, Mohsen Elalfy2, Ali Taher3, Yesim Aydinok4, Szu-Hee Lee5, Pranee Sutcharitchan6, Ali El-Ali7, Jackie Han8, Amal El-Beshlawy9.   

Abstract

BACKGROUND: In transfusion-dependent anaemias, while absolute serum ferritin levels broadly correlate with liver iron concentration (LIC), relationships between trends in these variables are unclear. These relationships are important because serum ferritin changes are often used to adjust or switch chelation regimens when liver magnetic resonance imaging (MRI) is unavailable. OBJECTIVES AND METHODS: This post hoc analysis of the EPIC study compared serum ferritin and LIC in 317 patients with transfusion-dependent thalassaemia before and after 1 yr of deferasirox.
RESULTS: Serum ferritin responses (decreases) occurred in 73% of patients, 80% of whom also have decreased LIC. However, 52% of patients without a serum ferritin response did decrease LIC and by >1 mg Fe/g dw (median 3.9) in 77% of cases. Absolute serum ferritin and LIC values correlated significantly only when serum ferritin was <4000 ng/mL (r = 0.59; P < 0.0001) and not at higher levels (≥4000 ng/mL; r = 0.19). Serum ferritin response was accompanied by decreased LIC in 89% and 70% of cases when serum ferritin was <4000 or ≥4000 ng/mL, respectively.
CONCLUSIONS: As serum ferritin non-response was associated with LIC decrease in over half of patients, use of liver MRI may be particularly useful for differentiating true from apparent non-responders to deferasirox based on serum ferritin trends alone.
© 2016 The Authors. European Journal of Haematology Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  chelation; deferasirox; liver iron concentration; serum ferritin; thalassaemia

Mesh:

Substances:

Year:  2017        PMID: 27859648     DOI: 10.1111/ejh.12830

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  8 in total

1.  Modern management of iron overload in thalassemia major patients guided by MRI techniques: real-world data from a long-term cohort study.

Authors:  Selen Bayraktaroglu; Nihal Karadas; Sebnem Onen; Deniz Yılmaz Karapinar; Yesim Aydinok
Journal:  Ann Hematol       Date:  2022-01-05       Impact factor: 3.673

2.  Iron and zinc homeostases in female rats with physically active and sedentary lifestyles.

Authors:  Andrew J Ghio; Joleen M Soukup; Caroline Ghio; Christopher J Gordon; Judy E Richards; Mette C Schladweiler; Samantha J Snow; Urmila P Kodavanti
Journal:  Biometals       Date:  2020-11-25       Impact factor: 2.949

3.  Serum or plasma ferritin concentration as an index of iron deficiency and overload.

Authors:  Maria Nieves Garcia-Casal; Sant-Rayn Pasricha; Ricardo X Martinez; Lucero Lopez-Perez; Juan Pablo Peña-Rosas
Journal:  Cochrane Database Syst Rev       Date:  2021-05-24

Review 4.  Deferasirox: Over a Decade of Experience in Thalassemia.

Authors:  Nour M Moukalled; Rayan Bou-Fakhredin; Ali T Taher
Journal:  Mediterr J Hematol Infect Dis       Date:  2018-11-01       Impact factor: 2.576

5.  Relationship between liver iron concentration determined by R2-MRI, serum ferritin, and liver enzymes in patients with thalassemia intermedia.

Authors:  Hayder Al-Momen; Shaymaa Kadhim Jasim; Qays Ahmed Hassan; Hayder Hussein Ali
Journal:  Blood Res       Date:  2018-12-17

6.  Cardiac and hepatic siderosis in myelodysplastic syndrome, thalassemia and diverse causes of transfusion-dependent anemia: the TIMES study.

Authors:  P Joy Ho; Devendra Hiwase; Raj Ramakrishna; Nicholas Viiala; Ann Solterbeck; Robert Traficante; Evren Zor; Othon L Gervasio; Laura M High; David M Ross; Donald K Bowden
Journal:  Hemasphere       Date:  2019-06-04

7.  Characterisation of individual ferritin response in patients receiving chelation therapy.

Authors:  Elisa Borella; Sean Oosterholt; Paolo Magni; Oscar Della Pasqua
Journal:  Br J Clin Pharmacol       Date:  2022-03-26       Impact factor: 3.716

8.  Monitoring Iron Overload: Relationship between R2* Relaxometry of the Liver and Serum Ferritin under Different Therapies.

Authors:  Michaela Plaikner; Christian Kremser; Heinz Zoller; Werner Jaschke; Benjamin Henninger
Journal:  J Clin Imaging Sci       Date:  2018-09-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.